TGFB1 and renal fibrosis: An effective peptide inhibitor for blocking TSPYL2 signaling axis in renal fibrosis has been developed.[9] The efficacy of this drug in alleviating the disease process in Tspyl1 KO mice, due to altered TGFβ or other cellular pathways, should be tested in the future.